Maraviroc bindes selektivt til human kemokin- receptor CCR5, idet den forhindrer CCR5- tropisme HIV- 1 i at komme ind i cellerne.
Maraviroc selectively binds to the human chemokine receptor CCR5, preventing CCR5-tropic HIV-1 from entering cells.